Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): Results of a case-control study

Oncology Reports

Volumn 7, Issue 1, 2000, Pages 169-170

  Nelson, Jon E ^a   Harris, Randall E ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Aspirin; Cyclooxygenase; Ibuprofen; Non steroidal anti inflammatory drugs; Prostate cancer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CASE CONTROL STUDY; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0033631452     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.1.169     Document Type: Article

References (16)

1. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-235, 1971.
2. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589, 1992.
3. Harris RE, Kasbari S and Farrar WB: Prospective study of non-steroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6: 71-73, 1999.
4. Harris, RE, Namboodiri KK and Farrar WB: Non-steroidal anti-inflammatory drugs and breast cancer. Epidemiology 7: 203-205, 1996.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and duBois RN: Up-regulation of cycloxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
6. Parrett ML, Harris RE, Joarder FS, Clausen KP and Robertson FM: Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10: 503-507, 1997.
7. Kawamori T, Rao CV, Siebert K and Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412, 1998.
8. Joarder FA, Abou-Issa H, Robertson FM, Parrett ML, Alshafie G and Harris RE: Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats. Oncol Rep 4: 1271-1273, 1997.
9. Schlesselman JJ: Case-control studies, design, conduct, analysis. Oxford University Press, New York, 1982.
10. Paganini-Hill A: Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 299: 1247-1250, 1989.
11. Thun MJ: Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327, 1993.
12. Norrish AE, Jackson RT and McRae CU: Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 77: 511-515, 1998.
13. Ghosh J and Myers CE: Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235: 418-423, 1997.
14. Rose DP and Connolly JM: Effects of fatty aids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18: 243-254, 1991.
15. Drago JR and Al-Mondhiry HA: The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res 4: 391-394, 1984.
16. Harris RE, Robertson FM, Abou-Issa HM, Farrar WB and Brueggemeier R: Genetic induction and upregulation of cyclo-oxygenease (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses 52: 291-292, 1999.